Warenkorb -  AGBs -  Datenschutz -  Contact us   

Management of Peritoneal Metastases - Cytoreductive Surgery, HIPEC and beyond


BHATT  

Management of Peritoneal Metastases - Cytoreductive Surgery, HIPEC and beyond

580 Seiten, 1. Auflage, 2018
84 Abbildungen

  • Covers all the recent developments in peritoneal surface oncology
  • Includes the basics of CRS and HIPEC like patient selection, surgical technique, HIPEC methodologies
  • Covers individual diseases with an update on the recent developments
  • Offers practical suggestions and tips at the end of each chapter
This book provides comprehensive reviews on the various aspects of managing peritoneal metastases. The authors highlight essential practical issues that surgical oncologists encounter in their day-to-day practice, and provide evidence-based solutions to address them. All chapters were written and/or reviewed by leading experts in this field.

The widespread acceptance among the oncology community at large of cytoreductive surgery and HIPEC as a potentially curative treatment for peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients. Much has been and continues to be published on this subject.

Table of Contents
  • Evolving role of CRS and HIPEC: Current Indications, prevention and early treatment of peritoneal metastases
  • Cytoreductive surgery: Patient selection, surgical techniques, and laparoscopic CRS
  • HIPEC: Methodology, comparison of techniques, drug regimens. Is there a need for standardization?
  • EPIC: Current role and future perspective
  • Management of complications of CRS and HIPEC
  • Imaging for PSM: Utility of MRI and PET CT
  • Clinical trials in CRS and HIPEC: Ongoing trials and future directives
  • Rare peritoneal tumors: Indications for CRS and HIPEC
  • Management of recurrent ovarian cancer
  • IP chemotherapy in the management of colorectal cancer
  • PMP and appendiceal tumors: Classification systems and pitfalls, biomarkers, current treatment standards, and role of systemic therapy
  • Malignant peritoneal mesothelioma
  • PIPAC for the management of peritoneal metastases
  • Quality of life issues in patients after CRS and HIPEC
  • Palliative treatment options for patients with unresectable peritoneal metastases
  • Registries and collaborative groups in peritoneal surface oncology

€ 96,29
   
versandkostenfrei - in acht bis zehn Werktagen lieferbar Anzahl:
Preis: € 96,29